Compass Pathways Plc
Sector: Manufacturing
Industry: Pharmaceutical Products
3.91
0.12
(3.17%)
Volume:
587,606
52 week range:
2.49 - 8.54
Market Cap:
365.826M
Company Description:
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression. The company was formerly known as COMPASS Rx Limited.